SE454746B - Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider - Google Patents

Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider

Info

Publication number
SE454746B
SE454746B SE8101585A SE8101585A SE454746B SE 454746 B SE454746 B SE 454746B SE 8101585 A SE8101585 A SE 8101585A SE 8101585 A SE8101585 A SE 8101585A SE 454746 B SE454746 B SE 454746B
Authority
SE
Sweden
Prior art keywords
glycine
oligopeptides
tripeptides
composition according
dipeptides
Prior art date
Application number
SE8101585A
Other languages
English (en)
Swedish (sv)
Other versions
SE8101585L (sv
Inventor
S A Adibi
Original Assignee
Montefiore Hospital Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montefiore Hospital Ass filed Critical Montefiore Hospital Ass
Publication of SE8101585L publication Critical patent/SE8101585L/
Publication of SE454746B publication Critical patent/SE454746B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
SE8101585A 1980-03-14 1981-03-12 Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider SE454746B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13030980A 1980-03-14 1980-03-14
US06/227,127 US4340592A (en) 1980-03-14 1981-01-26 Nutrient compositions and method of administering the same

Publications (2)

Publication Number Publication Date
SE8101585L SE8101585L (sv) 1981-09-15
SE454746B true SE454746B (sv) 1988-05-30

Family

ID=26828352

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101585A SE454746B (sv) 1980-03-14 1981-03-12 Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider

Country Status (9)

Country Link
US (1) US4340592A (de)
AT (1) AT372281B (de)
AU (1) AU543401B2 (de)
CH (1) CH646874A5 (de)
DE (1) DE3108079C2 (de)
FR (1) FR2477843A1 (de)
GB (1) GB2071670B (de)
NL (1) NL190951C (de)
SE (1) SE454746B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
EP0181342B1 (de) * 1984-03-01 1992-10-28 ERK, Vernon Behandlungsverfahren gegen hohen blutdruck bei wirbeltieren
WO1985003872A1 (en) * 1984-03-01 1985-09-12 Vernon Erk Method of lowering blood sugar level in vertebrates
AU598443B2 (en) * 1984-03-01 1990-06-28 Vernon Erk A method of treating hypoglycemia in vertebrates
AU599567B2 (en) * 1984-03-01 1990-07-26 Vernon Erk Method of treating memory disorders of the elderly
CA1257806A (en) * 1984-11-19 1989-07-25 Siamak A. Adibi Nutrient compositions
US5034377A (en) * 1984-11-19 1991-07-23 Montefiore Hospital Association Of Western Pennsylvania Aqueous nutrient compositions comprising oligopeptides
JPS62149619A (ja) * 1985-09-05 1987-07-03 Teijin Ltd 活性型ビタミンｄ３類注射用組成物
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
EP0347890B1 (de) * 1988-06-22 1993-03-17 Roussel Morishita Co., Ltd. Aminosäure-Nahrungsmittelzusammensetzungen
EP0416108B1 (de) * 1989-03-28 1993-10-20 Kyowa Hakko Kogyo Co., Ltd. Nahrungsmittelzusammensetzung
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
US5122515A (en) * 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
DE4022267C2 (de) * 1990-07-12 1994-09-15 Degussa N-Acyldipeptide und deren Verwendung
US5167957A (en) * 1990-09-06 1992-12-01 Virginia Tech Intellectual Properties, Inc. Compositions and methods for the treatment of dietary deficiencies
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
JPH06227974A (ja) * 1993-01-29 1994-08-16 Kyowa Hakko Kogyo Co Ltd 栄養組成物
US5891459A (en) * 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US7371415B1 (en) 1998-04-03 2008-05-13 The Daily Wellness Company Method and composition for improving sexual fitness
WO1999051252A1 (en) 1998-04-03 1999-10-14 The Daily Wellness Company Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
CA2376375C (en) * 1999-06-05 2011-07-12 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
US7855181B2 (en) * 1999-08-13 2010-12-21 University Of Florida Research Foundation, Inc. Dipeptides for prevention of muscle breakdown and microbial infection
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US7153822B2 (en) * 2002-01-29 2006-12-26 Wyeth Compositions and methods for modulating connexin hemichannels
US20060229256A1 (en) * 2003-09-26 2006-10-12 Bristol-Myers Squibb Company Enternal administration of arginine and glutamine for abnormal vascular proliferation
US7148199B2 (en) * 2003-09-26 2006-12-12 University Of Florida Research Foundation, Inc. Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
JP2007526316A (ja) * 2004-03-01 2007-09-13 ルーメン セラピューティックス リミテッド ライアビリティ カンパニー 疾患を処置するための組成物および方法
JP5198065B2 (ja) * 2005-09-20 2013-05-15 協和発酵バイオ株式会社 ジペプチド含有経口用組成物
EP2789341A3 (de) 2005-11-11 2015-01-14 V. Ravi Chandran O-Acetylierte Aminosäuren als Antitrombozytenmittel und Ernährungsergänzungsmittel
US8343531B2 (en) * 2006-04-21 2013-01-01 Meiji Co., Ltd. Composition containing peptide as active ingredient
EP2067044B1 (de) * 2006-09-12 2013-07-03 F. Hoffmann-La Roche AG Assay für antikörper gegen arzneistoff
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
CN107744140A (zh) * 2017-11-06 2018-03-02 威海红印食品科技有限公司 一种预消化型全营养液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH591918A5 (de) * 1974-03-05 1977-10-14 Nestle Sa
CH594367A5 (de) * 1974-05-17 1978-01-13 Brenner Beat Max
US4024286A (en) * 1976-05-17 1977-05-17 Miles Laboratories, Inc. Fortification of foodstuffs with C-terminal amino acid substituted methionine dipeptides
US4127534A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tripeptides, intermediates therefor and pharmaceutical compositions and methods employing said tripeptides

Also Published As

Publication number Publication date
NL190951B (nl) 1994-06-16
AT372281B (de) 1983-09-26
DE3108079A1 (de) 1982-01-21
AU6833881A (en) 1981-09-17
FR2477843A1 (fr) 1981-09-18
US4340592A (en) 1982-07-20
CH646874A5 (de) 1984-12-28
NL190951C (nl) 1994-11-16
FR2477843B1 (de) 1985-03-22
NL8101182A (nl) 1981-10-01
SE8101585L (sv) 1981-09-15
GB2071670B (en) 1983-07-13
AU543401B2 (en) 1985-04-18
DE3108079C2 (de) 1986-01-16
ATA117581A (de) 1983-02-15
GB2071670A (en) 1981-09-23

Similar Documents

Publication Publication Date Title
SE454746B (sv) Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider
JP2644086B2 (ja) 外傷及び外科患者のための栄養製剤
Rerat et al. Splanchnic fluxes of amino acids after duodenal infusion of carbohydrate solutions containing free amino acids or oligopeptides in the non-anaesthetized pig
US5716926A (en) Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US5756481A (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction in animals and man
JPH07507327A (ja) 神経系損傷を有するヒトのための栄養製剤
CN102014947B (zh) 富含亮氨酸的肽组合物和分离方法
EP0758234A1 (de) Verfahren und zusammensetzung zur behandlung von nierenerkrankungen und nierenversagen
EP0457314A1 (de) Peptide enthaltende nahrhafte Zusammensetzungen
US5292722A (en) Intravenous solution that diminishes body protein loss
Naylor Oral electrolyte therapy
EP0075594A1 (de) Glukosepolymere, sowie verfahren zur herstellung derselben
Heird Feeding the premature infant: human milk or an artificial formula?
CA2134380C (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
Madden et al. BLOOD PLASMA PROTEIN PRODUCTION AND UTILIZATION: The Influence of Amino Acids and of Sterile Abscesses
Welters et al. Supplementation of enteral nutrition with butyrate leads to increased portal efflux of amino acids in growing pigs with short bowel syndrome
Cuthbertson et al. Nutrition in the post-traumatic period
Rollins et al. Three‐in‐one parenteral nutrition: a safe and economical method of nutritional support for infants
JPS6326733B2 (de)
Robscheit-Robbins et al. Gelatin—Its usefulness and toxicity: Blood protein production impaired by continued gelatin by vein
JPH09110686A (ja) マクロファージ一酸化窒素産生亢進剤
JPS5923291B2 (ja) アミノ酸および無機塩を含有する注入液
Børresen Balanced intravenous nutrition in pediatric surgery
Johnston The role of parenteral nutrition in surgical care.
SE442480B (sv) Forfarande for framstellning av en glukoshaltig infusionslosning

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101585-1

Format of ref document f/p: F

SPCF Application for supplementary protection certificate filed

Free format text: 9690012, 951122

SPCG Supplementary protection certificate granted

Free format text: 9690012, 951122, EXPIRES: 20060312

NUG Patent has lapsed

Ref document number: 8101585-1

Format of ref document f/p: F